1705 – Structured prenatal risk assessment for preterm preeclampsia

Page last updated: 09 February 2024

Application Detail

Description of Medical Service

Pre-term preeclampsia risk assessment performed using a multi-variate testing algorithm at 11-13+6 weeks’ gestation. The algorithm includes:
  • Clinical measurement of maternal Mean Arterial Pressure
  • Biochemical measurement of maternal serum concentration of Placental Growth Factor; and
  • Ultrasound assessment of uterine perfusion (Doppler measurement of uterine artery pulsatility index).

Description of Medical Condition

Preeclampsia is a pregnancy-specific condition resulting in maternal hypertension (high blood pressure) and multisystem dysfunction. Once preeclampsia develops, it becomes progressively worse until infant delivery. Preterm preeclampsia is a more severe form of disease with earlier onset that causes more cardiovascular morbidity for mothers in later life. The preeclamptic fetus is often growth restricted. Planned pre-term birth puts the surviving fetus at substantially increased risk of death or lifelong morbidity.

Reason for Application

New MBS item

Medical Service Type

Investigative medical technology

Previous Application Number/s

Not Applicable

Associated Documentation

Application Form

Application Form (PDF 1152 KB)
Application Form (Word 120 KB)

Consultation Survey

Consultation Survey (PDF 688 KB
Consultation Survey (Word 72 KB)

PASC Consultation
Consultation Closed

MSAC Consultation
MSAC consultation closed Friday, 6 October 2023.

For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation

PICO Confirmation (PDF 1073 KB)
PICO Confirmation (Word 849 KB)

Assessment Report


Public Summary Document

Public Summary Document (PDF 948 KB)
Public Summary Document (Word 301 KB)

Meetings for this Application


13-14 April 2022


5-6 October 2023


23-24 November 2023